Evidence map›Paper›PMID 39310271›Full record

ArticleOpen forum infectious diseases2024

Evaluation of a Ureteral Stent Removal Protocol in Adult Kidney Transplant Recipients.

Paula M Krzos, Cynthia T Nguyen, Brenna Kane, Sambhavi Krishnamoorthy, Tanya W Kristof, Luke F Reynolds, Jennifer Pisano, Michelle A Josephson, Rolf Barth, Derek Owen

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paula M KrzosDepartment of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0006-6872-3282
Cynthia T NguyenDepartment of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-8530-6890
Brenna KaneDepartment of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.
Sambhavi KrishnamoorthySection of Nephrology, Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-4701-785X
Tanya W KristofDivision of Urology, Department of Surgery, University of Chicago Medicine, Chicago, Illinois, USA.
Luke F ReynoldsDivision of Urology, Department of Surgery, University of Chicago Medicine, Chicago, Illinois, USA.
Jennifer PisanoSection of Infectious Diseases and Global Health, Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-8156-3731
Michelle A JosephsonDepartment of Surgery, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-3426-0794
Rolf BarthDivision of Transplantation, Department of Surgery, University of Chicago Medicine, Chicago, Illinois, USA.
Derek OwenDepartment of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0003-1157-7710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing literature on best practices to reduce the risk of infectious complications associated with ureteral stent removal in kidney transplant recipients is limited. Prior to 2021, a formal process surrounding stent removal was not in place at our institution. In June 2021, a stent removal protocol was established. This protocol included the following: obtaining a preprocedure urine culture, prescribing universal culture-directed antimicrobial prophylaxis, earlier stent removal posttransplant, and patient education. We performed a retrospective quasi-experimental study of kidney transplant recipients who had their stents removed between July 2020 and June 2022. The primary outcome was the incidence of infectious complications within 30 days. Infectious complications were defined as urinary tract infection and bacteremia due to urinary source, as well as hospitalization, emergency department visit, or outpatient encounter for possible urinary tract infection. Secondary objectives included infectious and immunologic complications within 30 days to 1 year from transplant. During this study period, 239 adult kidney transplant recipients were included: 88 in the preprotocol group and 151 in the protocol group. The median time to stent removal was shorter in the protocol group (25 vs 36 days,

Indexed as

antibioticantimicrobialkidneyorgan transplantprophylaxis

Identifiers

PMID39310271
PMCPMC11414405

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.